Business Context and Reporting Period
This Form 8-K is a current report filed by Prestige Brands Holdings, Inc. (now Prestige Consumer Healthcare Inc.) on March 5, 2012, covering events occurring on February 29, 2012. The filing primarily addresses executive departures and corporate governance updates regarding the annual stockholder meeting.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to severance compensation for a departing officer:
- Severance Package: One year's salary plus average annual incentive bonus and medical coverage.
- Additional Bonus: $50,000 for fiscal year 2013.
- Additional Payment: $20,000 payable on March 30, 2012.
- Stock Options: Accelerated vesting of 11,601 options at $9.03/share and 2,378 options at $11.27/share.
Material Changes
The primary material change reported is the resignation of Eric S. Klee as General Counsel and Secretary, effective February 29, 2012, to pursue other opportunities. No material changes to financial operations or strategic direction are disclosed in this report.
Guidance, Outlook, and Corporate Events
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of risks and contingencies. However, it notes the following corporate governance events:
- Annual Meeting: Scheduled for June 29, 2012.
- Proposal Deadline: The deadline for Rule 14a-8 stockholder proposals was March 2, 2012.
- Nomination Deadline: Stockholder nominations for directors or other business items must be received by March 15, 2012.
Investor Verification Checklist
- Verify the appointment of a new General Counsel and Secretary to replace Eric S. Klee.
- Confirm the total cost of the severance package and its impact on the upcoming quarter's expenses.
- Review the proxy statement for the June 29, 2012 annual meeting for any new director nominations or business items.
- Check subsequent filings for any changes to the company's legal or compliance strategy following the departure of the General Counsel.